Your browser doesn't support javascript.
loading
Emerging multimodality imaging techniques for the pulmonary circulation.
Rajagopal, Sudarshan; Bogaard, Harm J; Elbaz, Mohammed S M; Freed, Benjamin H; Remy-Jardin, Martine; van Beek, Edwin J R; Gopalan, Deepa; Kiely, David G.
Afiliación
  • Rajagopal S; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Bogaard HJ; Department of Pulmonology, Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, The Netherlands.
  • Elbaz MSM; Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Freed BH; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Remy-Jardin M; IMALLIANCE-Haut-de-France, Valenciennes, France.
  • van Beek EJR; Edinburgh Imaging, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK.
  • Gopalan D; Department of Radiology, Imperial College Healthcare NHS Trust, London, UK d.gopalan@nhs.net.
  • Kiely DG; Sheffield Pulmonary Vascular Disease Unit and NIHR Biomedical Research Centre Sheffield, Royal Hallamshire Hospital, Sheffield, UK.
Eur Respir J ; 2024 Aug 29.
Article en En | MEDLINE | ID: mdl-39209480
ABSTRACT
Pulmonary hypertension (PH) remains a challenging condition to diagnose, classify and treat. Current approaches to the assessment of PH include echocardiography, ventilation/perfusion scintigraphy, cross-sectional imaging using computed tomography and magnetic resonance imaging, and right heart catheterisation. However, these approaches only provide an indirect readout of the primary pathology of the disease abnormal vascular remodelling in the pulmonary circulation. With the advent of newer imaging techniques, there is a shift toward increased utilisation of noninvasive high-resolution modalities that offer a more comprehensive cardiopulmonary assessment and improved visualisation of the different components of the pulmonary circulation. In this review, we explore advances in imaging of the pulmonary vasculature and their potential clinical translation. These include advances in diagnosis and assessing treatment response, as well as strategies that allow reduced radiation exposure and implementation of artificial intelligence technology. These emerging modalities hold the promise of developing a deeper understanding of pulmonary vascular disease and the impact of comorbidities. They also have the potential to improve patient outcomes by reducing time to diagnosis, refining classification, monitoring treatment response and improving our understanding of disease mechanisms.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur Respir J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur Respir J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido